| 4569 |
Kyorin Pharmaceutical Co., Ltd.
|
Strategy |
|
Development of New Mid-Term Management Plan ‘Vision 110 －Stage2－’ (FY2026–FY2029)
|
May 12, 2026
|
| 4569 |
Kyorin Pharmaceutical Company Limited
|
Earnings |
|
Q1 Financial Summary for the Fiscal Year Ending March 2026 (Consolidated, Japanese GAAP)
|
May 12, 2026
|
| 4569 |
Kyorin Pharmaceutical Co., Ltd.
|
Earnings |
|
Kyorin Pharmaceutical 2026 Full-Year Earnings Forecast Revision ｜ Sales ¥126,257 million (YoY -0.6%)
|
May 12, 2026
|
| 4569 |
Kyōrin Pharmaceutical
|
Earnings |
|
【Kyōrin Pharmaceutical】2026 Financial Results Supplementary Materials | Sales of 126.2 billion yen, Net Profit of 3.4 billion yen
|
May 12, 2026
|
| 4569 |
Kyourin Pharmaceutical Co., Ltd.
|
Earnings |
|
Financial Summary for the Fiscal Year Ending March 2026 [Japanese Standards] (Consolidated)
|
May 12, 2026
|
| 4536 |
Santen Pharmaceutical Co., Ltd.
|
Earnings |
|
【Santen Pharmaceutical】2026 Financial Results｜Sales of 291.6 billion yen (△2.8%)
|
May 12, 2026
|
| 4507 |
Shionogi & Co., Ltd.
|
Earnings |
|
FY2025 Financial Results Explanation Materials
|
May 12, 2026
|
| 4507 |
Shionogi & Co., Ltd.
|
Earnings |
|
【Shionogi & Co., Ltd.】2026 Financial Results Supplemental Materials | Sales of JPY 499.7 billion (Up 14.0% Year-over-Year)
|
May 12, 2026
|
| 4507 |
Shionogi & Co., Ltd.
|
Earnings |
|
【Shionogi & Co., Ltd.】2026 Fiscal Year Earnings｜Sales of ¥499.7 billion (Up 14.0% YoY)
|
May 12, 2026
|
| 4452 |
Kao Corporation
|
Earnings |
|
FY2026 Q1 Consolidated Financial Results Overview
|
May 12, 2026
|
| 4452 |
Kao Corporation
|
Earnings |
|
【Kao】Q1 FY2026 Financial Results | Sales of ¥413.2 billion (YoY +6.0%)
|
May 12, 2026
|
| ---- |
Finatext Holdings Ltd.
|
Earnings |
|
Fiscal Year 2025 Full-Year Financial Results Explanation Materials and Growth Potential
|
May 12, 2026
|
| 4419 |
Finatext Holdings Co., Ltd.
|
Earnings |
|
Financial Results for FY2026 | Revenue of 1.105 billion yen (43.5% YoY increase)
|
May 12, 2026
|
| 4384 |
Laxaro Corporation
|
Strategy |
|
Announcement of Share Consolidation and Delisting | Laxaro May 2026
|
May 12, 2026
|
| 4307 |
Nomura Research Institute, Ltd.
|
Dividend |
|
Notice Regarding Dividend of Surplus
|
May 12, 2026
|
| 4259 |
ExaWizards Inc.
|
Dividend |
|
Notice of Change in Shareholder Return Policy and Start of Dividends | May 12, 2026
|
May 12, 2026
|
| 4259 |
ExaWizards Inc.
|
M&A |
|
[ExaWizards] Notice of Business Restructuring and Subsidiary Integration | May 2026
|
May 12, 2026
|
| 4259 |
ExaWizards Inc.
|
Earnings |
|
Financial Summary for the Fiscal Year Ending March 2026
|
May 12, 2026
|
| 4259 |
ExaWizards Inc.
|
Earnings |
|
[ExaWizards] Latest Financial Results and Capital Policy for 2026 | May 2026
|
May 12, 2026
|
| 4259 |
ExaWizards
|
Earnings |
|
Notice of Deferred Tax Assets and Special Losses Recognition | May 2026
|
May 12, 2026
|
